Provided by Tiger Trade Technology Pte. Ltd.

Lixte Biotechnology Holdings Inc.

3.09
+0.12504.22%
Post-market: 3.090.00000.00%16:10 EDT
Volume:61.78K
Turnover:183.66K
Market Cap:26.89M
PE:-2.55
High:3.24
Open:2.99
Low:2.87
Close:2.97
52wk High:6.26
52wk Low:0.6400
Shares:8.70M
Float Shares:7.99M
Volume Ratio:0.87
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2110
EPS(LYR):-1.5943
ROE:-130.06%
ROA:-68.32%
PB:11.40
PE(LYR):-1.94

Loading ...

Lixte Biotech (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership

TIPRANKS
·
Yesterday

LIXTE Biotechnology (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape

TIPRANKS
·
Mar 24

Lixte Biotechnology Raises CEO Compensation Amid Leadership Support

TIPRANKS
·
Mar 21

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM

Reuters
·
Mar 12

Lixte Amends Share Exchange, Clarifies Liora Ownership Structure

TIPRANKS
·
Mar 11

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline

TIPRANKS
·
Mar 11

LIXTE Biotechnology (NASDAQ: LIXT) Advances Lead Compound in Tumor Immunogenicity Research

TIPRANKS
·
Mar 10

Powell Max names Geordan Pursglove chairman and CEO

Reuters
·
Mar 09

Powell Max Limited Successfully Repositions for Its Next Phase of Growth

GlobeNewswire
·
Mar 09

LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary

TIPRANKS
·
Feb 19

Lixte Subsidiary Liora Technologies Europe Names Sidney Braun CEO

Reuters
·
Feb 18

Lixte Biotechnology Appoints Sidney Braun as CEO of Its Liora Technologies Europe Ltd. Subsidiary

THOMSON REUTERS
·
Feb 18

LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment

TIPRANKS
·
Feb 10

Improving the Odds: How LIXTE Biotechnology (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

TIPRANKS
·
Feb 06

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy

TIPRANKS
·
Jan 24

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit

TIPRANKS
·
Jan 22

Lixte Biotechnology Holdings to Participate in DealFlow Discovery Conference in Atlantic City

Reuters
·
Jan 20

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK

TIPRANKS
·
Jan 09

Lixte Biotechnology Announces Unregistered Share Exchange with Orbit Capital

Reuters
·
Jan 01

Lixte Biotechnology Holdings Inc - Expands Collaboration With University of Texas Md Anderson Cancer Center & GSK for Lb-100

THOMSON REUTERS
·
Dec 23, 2025